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Abstract
Epigenetic marks such as cytosine methylation are important determinants of cellular and whole-body phenotypes.
However, the extent of, and reasons for inter-individual differences in cytosine methylation, and their association with
phenotypic variation are poorly characterised. Here we present the first genome-wide study of cytosine methylation at
single-nucleotide resolution in an animal model of human disease. We used whole-genome bisulfite sequencing in the
spontaneously hypertensive rat (SHR), a model of cardiovascular disease, and the Brown Norway (BN) control strain, to
define the genetic architecture of cytosine methylation in the mammalian heart and to test for association between
methylation and pathophysiological phenotypes. Analysis of 10.6 million CpG dinucleotides identified 77,088 CpGs that
were differentially methylated between the strains. In F1 hybrids we found 38,152 CpGs showing allele-specific methylation
and 145 regions with parent-of-origin effects on methylation. Cis-linkage explained almost 60% of inter-strain variation in
methylation at a subset of loci tested for linkage in a panel of recombinant inbred (RI) strains. Methylation analysis in
isolated cardiomyocytes showed that in the majority of cases methylation differences in cardiomyocytes and non-
cardiomyocytes were strain-dependent, confirming a strong genetic component for cytosine methylation. We observed
preferential nucleotide usage associated with increased and decreased methylation that is remarkably conserved across
species, suggesting a common mechanism for germline control of inter-individual variation in CpG methylation. In the RI
strain panel, we found significant correlation of CpG methylation and levels of serum chromogranin B (CgB), a proposed
biomarker of heart failure, which is evidence for a link between germline DNA sequence variation, CpG methylation
differences and pathophysiological phenotypes in the SHR strain. Together, these results will stimulate further investigation
of the molecular basis of locally regulated variation in CpG methylation and provide a starting point for understanding the
relationship between the genetic control of CpG methylation and disease phenotypes.
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Introduction
Cytosine methylation at CpG dinucleotides is a key epigenetic
mark with an essential role in regulating gene expression and other
cellular and whole body phenotypes. While the molecular
mechanisms for de novo and maintenance methylation of CpG
cytosines are well established [1–3], allele-specific influences on
CpG methylation have been documented [4–12], and association
of genotype and epigenotype has been shown in plants recently
[13], the extent of, and reasons for inter-individual differences in
cytosine methylation, and their association with phenotypic
variation in mammals are poorly characterised.
Isogenic inbred lines provide a powerful platform for establish-
ing relationships between the germline genome and downstream
phenotypes. The ability to breed experimental crosses, to study
multiple genetically identical animals, to minimise environmental
influences and to sample tissues as required are significant
advantages over comparable studies in humans. We have
generated extensive genetic, genomic and physiological resources
in our studies of the SHR, including expression datasets [14,15]
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and the SHR genome sequence [16,17] that have led to
identification of several genes underlying pathophysiological traits
in the SHR strain [18–22].
Given these resources and the relevance of SHR cardiac
phenotypes to related human disorders [18,19], we sought to
investigate cytosine methylation in the SHR heart. We applied
whole-genome bisulfite sequencing (WGBS) to multiple isogenic
animals from the SHR and BN strains, to test the hypothesis that
inter-individual variation in CpG dinucleotide methylation is
regulated by genomic DNA sequence and may be important in the
development of other genetically determined SHR phenotypes.
Results
We generated WGBS datasets from the left ventricles of four
BN and four SHR rats (European Nucleotide Archive accession
number ERP002215), producing a total of 1.3 and 1.5 billion
mapped reads in each strain. This was equivalent to 40–506mean
strand-specific read coverage per strain, and .286 mean
coverage after quality filtering and removal of clonal and non-
uniquely mapped reads (Table S1). Of the ,40 million CpG
dinucleotides covered by mapped reads on either strand in either
strain, we focus here on the 10,614,445 CpG dinucleotides that
were sequenced at a coverage depth of at least 56 strand-specific
reads across a minimum of three animals per strain (Figure S1).
Hierarchical clustering of the methylation profiles showed that
CpG dinucleotide methylation was more variable between strains
than within strains. The average distance between methylation
profiles of animals within each strain (average distance
BN=5,255, average distance SHR=5,430) was ,5 times lower
than the average distance between animals across strains (average
distance BN-SHR=24,281) (Figure 1A). To quantify the contri-
bution of strain specific differences to the variation in methylation
measurements we carried out a principal component analysis
which showed that the first principal component which separates
the methylation profiles by strain explains 28.13% of the total
variance (Figure 1B). No differences in global methylation levels
between the strains were detected by pyrosequencing (Figure S2).
These data suggested that differences in CpG dinucleotide
methylation may be at least in part dependent on genomic
sequence variation. To test this hypothesis we investigated the
relationship between genome-wide inter-strain methylation differ-
ences and inter-strain differences in genomic DNA sequence.
First, we defined a set of CpG dinucleotides that were
differentially methylated between animals from the SHR and
BN strains. Of the 10,614,445 analysed CpG dinucleotides, 77,088
(0.7%) were significantly differentially methylated between the two
strains (false discovery rate (FDR) ,5%). Of the 77,088
differentially methylated CpGs, 47,775 cluster into 12,128
differentially methylated regions containing between 2 and 213
CpG dinucleotides, while 29,313 are single CpG dinucleotides that
are at least 500 bp away from the next differentially methylated
CpG dinucleotide (Figure S3). In more than 96% of differentially
methylated regions, methylation differences between strains at
individual CpGs were in the same direction. In line with previous
observations, the large majority of analysed CpG dinucleotides
were highly methylated ($80% methylation) (Figure S4) but a
significant fraction of CpG dinucleotides (2.9%) had very low
methylation (#10% methylation). Within CpG islands (CGIs),
differentially methylated CpGs were found equally across different
genomic features whilst outside CGIs, the proportion of differen-
tially methylated CpGs was increased around the transcription
start site (TSS) (Figure S5).
To determine whether differential methylation could be
associated with discrete molecular or cellular functions important
to the biological differences between SHR and BN rats, we carried
out a Gene Ontology analysis of genes overlapping with or in close
proximity (within 5000 bp) of differentially methylated regions
containing five or more differentially methylated CpGs. Based on
these criteria 2,525 differentially methylated regions were associ-
ated with 1,283 genes. This set of genes showed strong enrichment
for gene products localised to the plasma membrane
(p = 1.2610214) or involved in neuron differentiation
(p = 2.961024) or cell communication (p= 2.961024) (Table S2).
Genetic analysis of CpG dinucleotide methylation
To validate WGBS methylation calls and to define a set of
differentially methylated CpG dinucleotides for genetic analysis,
we carried out Sanger sequencing and multiplexed Illumina
sequencing of PCR products generated from bisulfite converted
genomic DNA. We selected a set of CpG dinucleotides (Table S3)
in 40 regions (out of the 12,128 DMRs detected in the parental
strains) that showed between 1% and 93% differential methylation
between BN and SHR, were located at varying distances from
TSSs (the majority were within 3 kb of the TSS) and were within a
variety of genomic elements. By Sanger sequencing in BN and
SHR, there were 81 scoreable CpG dinucleotides for which 70
were covered in the WGBS data set. By multiplexed Fluidigm
amplification and Illumina sequencing, there were 131 scoreable
CpG dinucleotides, all of which were covered in the WGBS
dataset (Table S3). CpG methylation measured from bisulfite-
converted PCR-amplified products was highly concordant with
WGBS methylation data, both for the Sanger and for the
Fluidigm/Illumina-sequenced PCR products (rSanger = 0.86, p,
1024, Figure S6A; rFluidigm = 0.93, p,10
24, Figure S6B).
We next sought to map the genetic determinants of CpG
dinucleotide methylation of the 212 CpG dinucleotides residing
within the 40 amplicons in the BN- and SHR-derived BXH/
HXB panel of recombinant inbred (RI) strains [23,24], using
Author Summary
Epigenetic marks provide information that is not encoded
in the primary DNA sequence itself but in modifications of
genomic DNA and of the associated proteins. Methylation
of genomic DNA at cytosine residues is an important
epigenetic modification that is associated with develop-
mental processes, carcinogenesis and other diseases.
Genome-wide extent of, and reasons for inter-individual
differences in cytosine methylation, and their association
with phenotypic variation are poorly characterised. To
address these questions we have determined and com-
pared the genome-wide methylation patterns in heart
tissue of two inbred rat strains, the spontaneously
hypertensive rat, an animal model of human disease and
a control rat strain. Comparison of methylation differences
between genetically identical animals from the same strain
and differences between animals from different strains
allowed us to quantify association of epigenetic and
genetic differences. We show that differences in an
individual’s germline DNA sequence are important deter-
minants of the variability in methylation between individ-
uals. Comparison with previous reports implicates com-
mon mechanisms for regulation of cytosine methylation
that are highly conserved across species. Finally, we find
correlation between a proposed blood biomarker for heart
failure and variation in DNA methylation, suggesting a link
between germline DNA sequence variation, methylation
and a disease-related phenotype.
Genetic Control of CpG Methylation
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methylation percentage as a quantitative trait. Mean cytosine
methylation for 32 of the 40 amplicons mapped in cis (LOD
scores 4.8–23.3) and two in trans (LOD 4.9 and 6.1) (Table 1,
Figure 2, Figure S7). The remaining six amplicons showed no
linkage for mean CpG methylation although individual CpG
dinucleotides in three of these amplicons (Epha2 [EN-
SRNOG00000009222], Ppp1r13b [ENSRNOG00000012653],
Tbc1d30 [ENSRNOG00000023951]) showed strong cis linkage
(LOD 5.1–9.9; Fig. 2C, Figure S7, Table S3). Individual CpG
dinucleotides within all three of these amplicons showed opposing
allelic effects (Table S3), which was validated by amplicon
sequencing in the parentals (Figure S8), explaining the lack of
linkage to mean CpG methylation across these amplicons.
Individual CpGs within other amplicons generally showed similar
quantitative differences and directional change (Table S3). The
strength of linkage to methylation at individual CpG cytosines
was highly dependent on the difference in methylation between
the parental strains (Figure 3). We assessed the heritability of
cytosine methylation by segregation in the RI strains as
previously described [15] for the 32 amplicons for which cytosine
methylation was regulated in cis and found that the heritability of
mean amplicon methylation ranged from 12% to 99%, with
mean heritability being 62% (SD 22%). We also assessed
heritability by calculating the proportion of the linkage signals
at these 32 loci that was explained by cis linkage and found that,
on average 58% (SD 23%) of the total phenotypic variability in
mean methylation in the RI strains at these loci was explained by
cis linkage. Taken together, these data imply that methylation
Figure 1. Differential CpG methylation between the BN and SHR strains. A) Dendrogram showing the clustering the CpG methylation
profiles obtained in four BN and four SHR rats. B) Projection of methylation profiles onto the first principal component. Numbers after the strain label
denote biological replicates.
doi:10.1371/journal.pgen.1004813.g001
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percentage at most differentially methylated loci are regulated in
cis. In addition, the observed large sizes of the cis-QTL effects
suggest that these methylation phenotypes are essentially under
the control of a single locus, defined here as the extent of the
linkage region, and are strongly regulated in cis.
The differentially methylated CpG cluster at Odfp2 [EN-
SRNOG00000014584] on chromosome 3 was regulated in trans
by a locus on chromosome 2. Four of the seven protein-coding
genes in the 2-LOD linkage confidence interval – or trans-
regulated methylation quantitative trait locus (meth-QTL) -
Table 1. Meth-QTL amplicon linkage and methylation.
Gene IDa CGIb WGBS BNc WGBS SHRc WGBS differencec Meth-QTL statusd LOD score
Bcl11b no 33 61 228 cis 10.4
Cast yes 95 17 78 cis 12.6
Cbln1 yes 13 45 232 cis 11.5
Ccdc96 yes 70 7 63 cis 14.2
Cdkn2b no 17 29 213 cis 4.8
Ddhd1 yes 49 71 222 cis 10.4
E9PSL5_RAT no 65 75 210 cis 7.8
F1LUN1_RAT no 86 64 22 cis 14.5
F1M4B7_RAT no 68 40 28 cis 17.0
F1M804_RAT no 74 66 8 cis 5.2
F1M9Y3_RAT yes 3 23 220 cis 15.7
Fam198b no 75 54 21 cis 13.9
Fgd6 no 83 70 13 cis 6.5
Galnt12 yes 40 60 220 cis 12.1
Grm4 no 46 23 23 cis 13.6
Krt4 yes 82 39 43 cis 14.6
LOC100360843 yes 24 67 243 cis 8.7
LOC100365068 no 85 57 28 cis 10.8
Ly6e no 8 45 237 cis 9.6
Map4k5 no 17 56 239 cis 23.3
Naprt1 yes 9 32 223 cis 9.8
Nfam1 no 78 59 19 cis 13.8
Nsmaf no 68 55 13 cis 11.7
Nsmce2 no 82 72 10 cis 9.5
RGD1564053 no 64 76 212 cis 7.3
RGD1565350 no 47 32 15 cis 12.2
Rragc (F3) no 51 69 218 cis 9.2
Rragc (F4) yes 38 74 236 cis 11.4
Slc2a1 no 82 63 19 cis 18.1
Snapc1 yes 12 25 213 cis 9.6
Tmem178 yes 32 76 244 cis 18.0
Ttc22 yes 25 50 225 cis 7.2
Asap2 yes 84 91 27 trans 4.9
Odfp2 yes 30 49 219 trans 6.1
Akr1b10 yes 12 16 24 NSL 2.9
BI1_RAT yes 17 29 212 NSL 4.1
Epha2 yes 42 34 8 NSL 2.4
Ppp1r13b yes 66 66 0 NSL 3.3
Rtdr1 no 10 28 218 NSL 1.9
Tbc1d30 no 27 22 5 NSL 2.9
aGene ID indicates the closest gene to the amplicon.
b(CGI) within or overlaps with a CpG island.
c(WGBS) whole genome bisulfite sequencing, methylation percentage in BN and SHR strains, or difference between the strains (BN-SHR).
d(NSL) No significant linkage is defined as P.0.05 after a minimum of 1000 permutations of the linkage data.
Assay IDs are provided where there are two identical gene IDs.
doi:10.1371/journal.pgen.1004813.t001
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Figure 2. Multi-point linkage plots of meth-QTLs. (A) Linkage plots of 16 cis meth-QTLs with LOD scores .10 for linkage to mean CpG
methylation. LOD scores for linkage of average amplicon methylation levels are shown in red, LOD scores for linkage of individual CpG di-nucleotides
are shown in grey. The peak of linkage is indicated by a dashed, blue vertical line. (B) Linkage plot for the Odfp2 and Asap2meth-QTLs which showed
Genetic Control of CpG Methylation
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contain non-synonymous coding sequence variants between BN
and SHR and two of the six non-protein coding genes contain
sequence variants (Table S4). In an RNA-seq data set that we
generated from SHR and BN left ventricle (Table S5, ArrayEx-
press accession number E-MTAB-1702), we detected expression
for 8 of the 13 genes in the 2-LOD confidence interval, of which
three showed evidence of differential expression or alternative
splicing between BN and SHR (Table S4). None of the 13 genes in
the 2-LOD confidence interval nor their mouse or human
orthologues had Gene Ontology annotations related to DNA
methylation, chromatin status or DNA binding, suggesting a
potentially novel mechanism for trans-regulated methylation
caused by sequence variation or altered expression of one of the
protein-coding or non-protein-coding genes in this region. The
trans-regulated CpG cluster at Asap2 [ENSRNOG00000006056]
on chromosome 6 was regulated by a locus on chromosome 1. The
region of linkage contained more than 180 genes, many of which
showed either differential expression or coding sequence variation
between SHR and BN.
Because our studies of differential methylation were carried out
on intact heart tissue, it is possible that inter-strain differences in
methylation were due to differences in cellular composition of the
tissue samples rather than inter-strain differences in methylation
for a particular cell type. We therefore studied CpG methylation at
differentially methylated sites in cardiomyocytes and non-cardio-
myocytes isolated from intact SHR and BN heart. Whilst a small
proportion of differentially methylated loci showed methylation
differences that were in part dependent on cell type, in 69% of
cases methylation differences in cardiomyocytes and non-cardio-
myocytes were at least in part dependent on strain, and for 77% of
CpGs methylation differences were independent of cell type
(Figure S9, Table S6). A principal component analysis (PCA) of
methylation measurements (Figure 4) confirmed that the variation
in methylation is in large part explained by the strain background.
The first principal component (PC) which retains 43% of the
variance separates samples into BN and SHR while the second PC
which explains 20% of the variance distinguishes samples by tissue
(Figure 4A). Separate PCA of methylation measurements done in
each cell population, showed similar distribution of loadings for
the 1st PC (strain difference) in both cell populations (Figure 4B),
suggesting similar patterns of strain dependant methylation in the
two populations.
significant trans-linkages to chromosome 2 and 1 respectively whilst the amplicons reside on chromosomes 3 and 6. (C) Linkage plots of Epha2 and
Ppp1r13b for which the average methylation did not show significant linkage but individual CpG dinucleotides mapped in cis.
doi:10.1371/journal.pgen.1004813.g002
Figure 3. Correlation of CpG cytosine meth-QTL linkage and difference in CpG methylation between parental strains. Methylation
data were obtained from PCR amplification of bisulfite-treated DNA followed by Sanger or Illumina sequencing in parental and RI strains. CpGs were
classified according to linkage type (cis, trans, no significant linkage) and LOD scores were plotted against the absolute value of the difference in
methylation between parental strains. No linkage refers to CpGs for which permutation-based p$0.05. Correlation was assessed by Pearson r value.
The cluster of CpGs with .80% difference in methylation are all from a single amplicon selected because of high differential methylation in the
parental strains.
doi:10.1371/journal.pgen.1004813.g003
Genetic Control of CpG Methylation
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Correlation of variation in CpG methylation and
phenotypic variation
We carried out a quantitative trait methylation (QTM) analysis
to test for associations between variation in methylation and
phenotypic variation. We searched for correlation between
average methylation levels at the 40 loci previously tested for
genetic linkage (Table S3) and 241 physiological quantitative traits
measured across the RI strain panel. We found significant negative
correlation (Pearson’s r=20.75) of CpG methylation on
chr5:143,573,578–143,573,701 and serum chromogranin B
(CgB) levels (P=1.2761022, FDR=5%). Subsequent QTL
mapping for the serum chromogranin B trait located the peak of
linkage to chr5:143,426,944 (LOD score = 3.92, P=0.007) which
was identical to the peak of linkage of the methylation QTL that
correlated with the phenotype.
Sequence variation near differentially methylated CpG
dinucleotides
To identify genomic variants that may underlie cis-regulatory
control of CpG dinucleotide methylation, we analysed the distance
to the nearest SNP for all differentially methylated CpG
dinucleotides. We found an increased frequency (5-fold enrich-
ment) of CpG dinucleotides with closely adjacent SNPs in the set
of differentially methylated CpGs compared to the analysed set of
CpG dinucleotides and to all CpG dinucleotides in the genome
(Figure 5A). SNP enrichment in DNA adjacent to differentially
methylated CpG dinucleotides was not due to SNPs that disrupt
adjacent CpG dinucleotides because there was no enrichment of
CpG-disrupting SNPs at these sites (Figure 5A). There was an
increase in SNP frequency starting at around 250 bp from
differentially methylated CpGs with a further sharp increase
occurring within 5 bp of the differentially methylated CpG
dinucleotide (Figure 5B): 58.8% of differentially methylated CpGs
were no further then 250 bp away from a SNP, 5.3% had a SNP
within 5 bp. SNP proximity was, however, not associated with the
extent of differential methylation at the affected CpG dinucleotide
(Figure S10).
To investigate further the relationship between local SNP
density and differential methylation, we sought to determine
whether there was an association between nucleotide preference
within 5 bp of differentially methylated CpG dinucleotides and
either increased or decreased methylation. We observed prefer-
ential nucleotide usage for increased and decreased CpG
dinucleotide methylation within this 12 bp window with particu-
larly strong association in the 1–3 bp immediately adjacent to
differentially methylated CpGs (Figure 5C). The nucleotide
signatures that we identified were very similar to those recently
found to be associated with increased and decreased methylation
in mouse brain [12]. While the consensus sequence of the
nucleotide usage at hypermethylated CpG dinucleotides is
identical the consensus sequence at hypomethylated CpGs differs
only at a single position (Table S7). To quantify the observed
similarity we compared our position frequency matrices with those
obtained by Xie et al (personal communication) using the
TOMTOM comparison tool [25]. Both the nucleotide usage
patterns around hyper- as well as hypomethylated CpGs are highly
similar between rat heart and mouse brain (Phypo = 2.76610
210,
Phyper = 1.06610
210, Table S7).
After categorising SNP differences between BN and SHR 1 bp
up- and 1 bp downstream of the differentially methylated CpG we
found that SNPs which changed adenines and thymines into
guanines and cytosines both upstream and downstream of the
differentially methylated CpG more often resulted in increased
methylation in SHR than in BN (Figure S11). The nucleotide bias
associated in this study with increased and decreased CpG
methylation showed remarkable similarity to that found previously
in mouse brain [12] and in human blood [26].
Allele-specific methylation in reciprocal F1s
To study further the relationship between allelic sequence
variation and CpG dinucleotide methylation and to search for
possible parent-of-origin (PO) effects, we carried out WGBS of left
ventricle DNA from F1 animals from reciprocal crosses between
SHR and BN parents (Table S8). After filtering, we retained and
analysed approximately 25 million CpG dinucleotides (Figure S12,
Figure S13). This number was greater than in the parental strains
because of increased coverage in the F1 crosses compared to the
parental data sets. The absence of cross specific clusters in the
hierarchical clustering analysis (HCA) (Figure 6A) and the lack of
a clear separation of profiles by the 1st PC (Figure 6B), which
captured strain specific variation in the parentals, showed that the
variation in methylation profiles across animals within and
between the two crosses was small. Consistent with the small
variation in methylation we detected only 2,627 differentially
methylated CpG dinucleotides between the reciprocal crosses (,
0.01% of all analysed CpGs). This was less than one tenth of the
variability seen between the two parental strains, despite the
higher coverage in the F1 animals, reflecting the genetic
differences between the parental strains, but the identical genomes
(apart from the sex chromosomes) of all the F1 animals.
In order to detect allele-specific methylation (ASM) in the F1
animals, SNP-containing reads were phased by parental genotype.
Methylation profiles derived from the phased read data did cluster
by parental genotype (Figure 6C) and were separated by genotype
when projected on the 1st PC (Figure 6D). The absence of cross
specific sub-clusters is most likely due to the subtlety of
methylation differences between the cross which is smaller than
the technical variation of the method. Of the 2,170,074 CpG
dinucleotides testable for ASM differences after phasing, 38,152
showed significant ASM differences (FDR,5%). Because cis-
regulated differences in cytosine methylation should be detectable
as both differential methylation in the parental strains and as ASM
in the F1s, we looked for the intersection between the differentially
methylated CpG dinucleotides in the parental and the F1 datasets.
Of the 1,705,718 CpG dinucleotides analysed in both the parental
and phased F1 data (Figure 7A, intersection), there were 8,340
autosomal CpG dinucleotides differentially methylated in an
allele-specific manner in the F1s that were also differentially
methylated between BN and SHR parental strains (Figure 7B,
intersection). This number was 15 fold greater than expected by
chance (X2 = 137040.2, p,4.96102324). We observed the highest
enrichment for proximal sequence variation amongst the subset of
differentially methylated CpGs in the F1 dataset that were also
found to be differentially methylated in the parental strains
(Figure 7C). The increased frequency of local SNPs that we
observed in this set is further evidence of enrichment for putative
cis-regulatory sequence variants adjacent to differentially methyl-
ated CpG dinucleotides. The striking concordance of differential
methylation in the parental animals and allelically-determined
methylation in the F1 animals strongly suggests that the
methylation level at a large number (many thousands at least) of
CpG cytosines is regulated in cis, partly by local sequence
variation. The enrichment for SNPs in the 250 bp surrounding
differentially methylated CpGs, and particularly in the 10 bp
window around these CpGs (Figure 7C) indicates that sequence
variation in the immediate vicinity of differentially methylated
Genetic Control of CpG Methylation
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CpGs underlies at least part of these differences in cytosine CpG
methylation.
In addition to the finding of ASM differences in F1 animals, we
also identified 723 CpG dinucleotides within 145 regions that
were significantly differentially methylated (FDR,5%) in a PO-
specific manner (Table S9). In 35 regions we detected a mean
methylation difference between the paternal and maternal allele
of more than 50%. Twenty-five of these regions have been
reported previously as imprinted loci in human or mouse while
10 regions were previously undescribed (Table 2). To validate the
parent-of-origin specific methylation differences we measured
methylation by Fluidigm amplification and Illumina sequencing
at 15 loci (four known imprinted and eleven novel) at which we
detected PO-specific methylation by WGBS. The methylation
differences detected by WGBS at the selected loci ranged from
20–97%. Within these 15 loci, we were able to confirm parent-of-
origin dependent methylation differences for the four known
imprinted loci and five of the novel loci (F1LUE4_RAT-Sgk1,
5SrRNA-Pmfbp1, Col9a2, Mthfd2l, Region ID #97; Table S10).
Validation for one of the loci was only achieved on the BN
parental chromosome, most likely due to insertion deletion
polymorphisms on the SHR chromosome which led to the
absence of sequencing reads from the SHR chromosome at this
locus.
Table 3 and Figure 8 summarise methylation differences we
detected in this study by source of variation. Table 3 shows the
proportion of CpGs that were differentially methylated in the
analysis of i) inter-strain differences in methylation, ii) differential
methylation between reciprocal crosses, iii) allele specific methyl-
ation and iv) parent-of-origin dependent methylation. Figure 8
shows the distribution of methylation differences in the respective
analyses. CpGs methylated in a parent-of-origin dependent
manner exhibited the highest median difference in methylation
followed by CpGs that showed allele-specific methylation. The
small number of differentially methylated CpGs detected between
the F1 reciprocal crosses had a median methylation difference
similar to that of CpGs differentially methylated between the
parental strains albeit with a broader range of differences.
Discussion
Cytosine methylation at CpG dinucleotides is amongst the most
studied epigenetic marks, yet at present there is little information
about the extent to which inter-individual differences in CpG
methylation in adult tissues are genetically determined by germline
DNA sequence variation and how inter-individual variation in
methylation relate to whole-body phenotypes. Previous studies in
humans and experimental animals have shown evidence of
individual or allele-specific differences in methylation at CpG
cytosines [4–12]. However, these have either assayed methylation
at a small fraction of genomic loci, used low resolution techniques,
not taken account of SNPs that disrupt CpG sites, studied single or
small numbers of individuals, or only indirectly inferred the
difference between cis and trans regulation of CpG methylation.
We applied WGBS to assay CpG methylation at single-
nucleotide resolution across the genome in multiple isogenic
animals, and carried out segregation studies in F1s and linkage
studies in RI lines to define the extent and mode of inheritance of
inter-individual variation in CpG cytosines in the adult rat heart.
While methylation profiling has been carried out previously in the
rat [27] this is the first genome wide study at single nucleotide
resolution methylation to look at the association of genotype,
epigenotype and phenotype in an animal model of human disease.
Methylation studies in human heart tissue have used Illumina
BeadChip arrays [28] and MeDIP-seq [29] to examine cytosine
methylation in cardiomyopathy (CM). However, these studies did
not account for inter-individual germline differences in the genome
sequence which as we show here is an important determinant of
Figure 4. Principal component analysis (PCA) of methylation measurements in cardiomyocyte and non-cardiomyocyte cells
isolated from intact SHR and BN cardiac tissue. (A) Projection of samples onto the first two principal components (PC) of the methylation
measurements. (B) Comparison of loadings of the 1st PC (strain separation) of PCA of methylation measurements done in each cell population
separately.
doi:10.1371/journal.pgen.1004813.g004
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inter-individual variation in DNA methylation and may in part
explain the methylation differences observed in CM patients.
We measured cytosine methylation at over 10 million CpG sites
across the genome, showed that inter-strain variability in cytosine
methylation is markedly greater than intra-strain variability and
detected differential methylation between the strains at over
75,000 CpG cytosines, amounting to 0.7% of all analysed CpG
sites. Our studies in animals from parental strains, F1s and RI lines
show that inter-strain differences in CpG methylation are
substantially cis-regulated, essentially under control of sequence
variation at a single locus in cis defined as the extent of the linkage
region and the resolution of the genetic map which has an average
distance between genetic markers of ,2.7 MB. Furthermore, we
were able to demonstrate that the detected methylation differences
are largely independent of differences in tissue composition
between the two strains.
Our Gene Ontology analysis showed that genes that were
closest to differentially methylated regions, defined as a minimum
of five adjacent differentially methylated CpGs, were strongly
enriched for gene products localising to the plasma membrane, or
involved with neuron differentiation or cell communication.
Interestingly, a study of genetic variation in the SHR rat found
that genes showing major variation in their coding region between
SHR and BN also showed enrichment for genes encoding plasma
Figure 5. Sequence variation around differentially methylated CpGs. (A) Plot showing the frequency of CpGs with a SNP within 1 kb for all
CpG dinucleotides in the genome (red), all CpGs tested for differential methylation (blue), CpGs that showed a significant difference in methylation
between BN and SHR rats (green), and differentially methylated CpGs with a CpG-disrupting SNP in the vicinity (purple). In the latter case the distance
relates to the nearest CpG-disrupting SNP. (B) same plot as (A) zoomed in to the 10 bp interval around the CpG. (C) Sequence logos showing SNP
allele frequencies around differentially methylated CpGs for alleles associated with increased (top) and decreased (bottom) methylation.
doi:10.1371/journal.pgen.1004813.g005
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membrane components and neurological processes [16]. These
data suggest that, in addition to direct cis effects on methylation,
differential methylation near genes associated with the enriched
GO categories could be the result of genetic variation in genes
with similar biological function that act indirectly through
feedback mechanisms at the molecular or organismal level.
Although potentially of interest, such observations would require
more detailed investigation to confirm and understand these
associations. Furthermore, we find significant correlation between
CpG methylation and serum CgB levels. Serum CgB levels are a
correlate of sympathetic nervous system overactivity and have
been proposed as a biomarker for heart failure [30]. These
findings suggest a link between genetic, epigenetic and disease-
associated phenotypes the causal relationship of which remains to
be determined.
Analysis of genomic sequence showed that the 250 bp
surrounding differentially methylated CpGs are enriched for
sequence variants between the SHR and BN strains. We found
biases in nucleotide usage in the 5 bp immediately adjacent to
differentially methylated CpGs that are associated with increased
or decreased methylation. Remarkably, the nucleotide signatures
that we identified are almost identical to those recently identified
as being associated with increased and decreased methylation in
mouse brain [12] indicating near complete conservation across
tissues and species. Nearly identical signatures were also associated
with increased and decreased methylation in a separate analysis of
CpG methylation associated with ageing in human blood [26].
This extent of conservation across tissues and species suggests a
common mechanism contributing to regulation of CpG methyl-
ation that merits investigation in future studies.
Further to our findings of differential methylation in the
parental strains, we identified over 38,000 CpG dinucleotides that
showed allele-specific methylation in F1 animals. This finding of
allele-specific methylation in F1 animals is most likely due to cis-
regulatory mechanisms and is consistent with previous studies in
humans and mice reporting cis-regulation of CpG methylation [4–
10,12,31]. Our data define a genome-wide set of CpGs that are
susceptible to allele-specific regulation of CpG methylation in the
mammalian heart. Since in our study allele-specific methylation
could only be detected in F1 animals when sequence reads could
be phased by parental genotype, we could only seek the presence
of allele-specific methylation in 2.1 million of the total of more
than 25 million CpG dinucleotides in the rat genome. Accordingly
it is likely that the number of CpG dinucleotides influenced by cis-
regulated methylation is up to 10-fold greater than the 38,000
detected in this study in the genomes of these two strains.
Our studies in F1 animals also detected parent-of-origin (PO)
effects on DNA methylation with 723 CpG dinucleotides clustered
in 145 regions showing evidence of PO-type regulation of
methylation. To our knowledge, this is the first empirically-based
prediction of imprinted genes in the rat. Thirty-five of these
regions showed CpG methylation differences of more than 50%
between paternally and maternally-inherited alleles. Of these, 25
have been previously reported as imprinted loci in human and
mouse, including 19 identified recently in brain [12] while 10
regions were previously undescribed.
Figure 6. Hierarchical clustering and principal component analysis of CpG methylation profiles obtained in the F1 reciprocal
crosses. Dendrograms showing the results of clustering the CpG methylation profiles obtained in each of the F1 animals before (A) and after (C)
phasing the read data by parental genotype. The prefix of the phased F1 profiles in (C) denotes the reciprocal cross (bnxshr, shrxbn) and the suffix the
genotype of the phased read set (bn =Brown Norway, shr = Spontaneously Hypertensive Rat). Numbers after the reciprocal cross prefix denote
biological replicates. Profiles were clustered by the Ward’s method using the pairwise euclidean distance between the profiles as the distance metric.
Panels B and D show the projection of methylation profiles onto the 1st principal component (PC). Replicates for each cross-genotype combination
are separated along the y-axis. The prefix of the label denotes the reciprocal cross (bnxshr, shrxbn), the suffix denotes the parental genotype (bn, shr).
While the 1st PC does not separate crosses in the unphased data it provides complete separation by parental genotype in the phased data. Only CpGs
with at least 56coverage in each replicate/phased read set were included in the analysis and CpG positions affected by SNPs/indels were removed
prior to clustering and principal component analysis.
doi:10.1371/journal.pgen.1004813.g006
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The detected methylation differences ranged from a ,20%
median difference in the parental strains to ,50% median
difference for parent-of-origin specific methylation. The continu-
ous distribution of methylation differences and the practical
absence of mono-allelic methylation (i.e. 100% methylation on one
allele 0% methylation on the other) is probably explained by i) the
methylation measurements being composite signals coming from a
mix of different cell types present in the left ventricle and ii) the
stochastic nature of methylation reaction.
Our mapping studies in the BXH/HXB RI strains showed that,
treated as a quantitative trait, methylation at 151 of 212 CpGs,
residing within 36 amplicons, showed cis linkage with LOD scores
of 3.9–32.0. Most of these showed complete segregation of CpG
methylation with genotype indicating essentially single-locus
control in cis. Methylation of six CpGs in the Odfp2 amplicon
mapped in trans (LOD scores 3.6–7.6), with the trans-regulating
meth-QTL locus residing on a different chromosome to the
regulated CpGs. The fact that over 95% of the meth-QTLs for
individual CpGs that showed linkage in the RI strains were cis-
regulated is in keeping with our nucleotide preference data in the
parental strains, our cis/trans tests in the F1s, and with previous
data [11,12] that correlate local sequence variation with CpG
methylation status. The explanation for the two loci that showed
trans-regulated methylation is less clear. For Odfp2, there were no
candidate genes in the 2-LOD confidence interval of the trans
meth-QTL that had GO annotations related to DNA methylation,
chromatin status or DNA binding, suggesting either a novel
mechanism for regulation of DNA methylation, or possibly a role
for one of the several non-coding RNAs in this interval. For Asap2,
the large number of genes in the QTL interval precludes
assessment of candidates without further investigation. The finding
that methylation is predominantly regulated in cis complements
the analysis of SNP frequency adjacent to differentially methylated
CpGs. Both results point to the importance of cis regulation
although the underlying mechanisms and relative contribution of
proximal and distal sequence effects require further investigation.
Whilst a previous analysis has suggested that most cis-acting allelic
influences on CpG methylation may be up to 149 kb [9], our study
and that of Gibbs et al [6] detect allelic associations over much
shorter distances of 1–45 bp from differentially methylated CpGs.
The observed co-segregation of genotype and differential meth-
ylation is consistent with the results of a recent study of inbred lines
in plants [13], suggesting that cis-regulated control of inter-
individual variation in cytosine methylation is strongly conserved
across species and between animals and plants.
Many previous studies of CpG methylation have been carried
out in cell lines or homogeneous cell types isolated in primary
cultures, while we used whole cardiac tissue for these studies. The
spontaneously hypertensive rat is a model of cardiovascular disease
that has been extensively characterised genetically and phenotyp-
ically for hypertension, cardiac hypertrophy and failure and
insulin resistance [18–20,22,32–34] but the role of the cardiac
methylome in these phenotypes remains unexplored. It might be
expected that the study of whole tissue harvested ex vivo might
reduce our ability to detect genetic effects because of cell type
heterogeneity, possible paracrine effects or secondary effects of
whole-body phenotypes such as hypertension. Despite this, we find
consistent genetic effects on CpG methylation in cardiac tissue
from parental strains, F1 animals and RI lines derived from the
two parental strains. In particular, the finding that the CpG sites
Figure 7. Comparison of differential methylation in parental strains and allele-specific methylation in F1 crosses. (A) Venn diagram
showing the number of CpGs tested for differential methylation in the parental strains ONLY or for allele-specific methylation ONLY (grey areas) and
the fraction of CpGs tested for BOTH (intersection, blue). The light blue area shows the number of CpGs significantly differentially methylated
between the parentals AND/OR showing allele-specific methylation. Areas are not proportional. CpGs on the X chromosome and the mitochondrial
chromosome have been excluded. (B) Overlap of differential methylation between the parental strains and allele specific methylation in the F1s. In
total, 52,410 out of the 1,705,718 CpG dinucleotides analysed in both the parentals and the F1s (intersection, blue in (A)) showed significant
differential methylation. The Venn diagram shows the fraction of CpGs that were differentially methylated between the parents ONLY (purple),
between the alleles in the F1s ONLY (orange) or in BOTH (green). The theoretical distribution of frequencies assuming random overlap between the
parental and the F1 data sets are shown in italics (X2= 135276.2, P,4.96102324). The overlap of the two sets is .15 fold higher than expected by
chance. (C) Frequency of CpGs with a SNP within 50 base pairs for CpGs showing differential methylation between the parentals only (purple), the F1
alleles only (orange) and both (green) compared to all CpGs analysed in the parentals and the F1s (blue) and the whole genome (red).
doi:10.1371/journal.pgen.1004813.g007
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showing allele-specific methylation in F1 animals were enriched
15-fold (p,102324) for CpG sites also showing differences in CpG
methylation in the parental strains is evidence of the stability and
robustness of these genetic data.
Previous studies of gene expression showed that the heritability
of gene expression in heterogeneous compared to homogeneous
cell types is dominated by cis-regulated gene expression [35], and
also that expression differences that are found in single cell
populations may not be found in heterogeneous tissues [36]. By
analogy, it is possible that genetic analysis of DNA methylation in
more homogeneous cell populations than were studied here
would detect stronger cis effects and more extensive trans effects
on CpG methylation than were detected in our studies of intact
heart tissue. Notwithstanding, our study was able to detect strong
allelic effects on CpG cytosine methylation and, in addition, our
analysis of methylation differences in isolated cardiomyocytes
and non-cardiomyocytes showed that for the large majority (.
75%) of CpGs analysed in this study, differential CpG
methylation in the heart tissue was independent of cell type.
Taken together, these studies define a minimum extent of genetic
regulation of CpG methylation across these two rat strains in the
rat heart.
Materials and Methods
Strains and tissue processing
Rats were housed in an air-conditioned animal facility and
allowed free access to standard laboratory chow and water. All
experiments were done in agreement with the Animal Protection
Law of the Czech Republic and were approved by the Ethics
Committee of the Institute of Physiology, Czech Academy of
Sciences, Prague. We collected left ventricular tissue from unfasted
males from six week old male BN-Lx/Cub (referred to in this study
as BN), SHR/Olalpcv (referred to as SHR) (n = 4 per strain); and
from (BNxSHR)F1 and (SHRxBN)F1 (n= 4 per cross); and from
male rats from 29 BXH/HXB recombinant inbred strains (n = 2
per strain) [23] between 9:00am and 10:00am. Left ventricles were
snap frozen in liquid nitrogen and stored at 280uC. The BN-Lx/
Cub and SHR/Olalpcv lines have been inbred over more than 80
generations [17]. For tissue heterogeneity studies, cardiomyocytes
and non-cardiomyocytes were isolated as previously described [37]
from SHR/Ncrl and BN.NCrl rats (four biological replicates each)
and studied alongside whole heart tissue from the same strains, as
well as left ventricle tissue from SHR/Olalpcv and BN-Lx/Cub
rats (three biological replicates each). No differences were found
between the SHR/Olalpcv and BN-Lx/Cub and the respective
NCrl strains which are also referred to as SHR or BN in the
analysis of tissue heterogeneity.
Whole genome bisulfite sequencing (WGBS)
Frozen tissues from BN rats, SHR rats and the reciprocal F1
animals were processed without pooling to generate methylation
profiles on the HiSeq 2000 platform (Illumina) as described in [38].
Analysis of global DNA methylation levels using
Luminometric Methylation Assay (LUMA)
A luminometric-based assay for global DNA methylation was
performed according to the protocol described in [39]. Briefly,
250 ng of genomic DNA extracted from liver (n = 3), kidney (n= 3)
and left ventricle (n = 4) of BN and SHR animals was subjected to
double-digestion with EcoRI and methylation-sensitive HpaII and
methylation insensitive MspI restriction endonucleases and global
methylation between strains quantified by pyrosequencing.
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RNA-seq library preparation and data collection
RNA was extracted from 25 mg of crushed left ventricular tissue
from four BN and four SHR animals without pooling, using Trizol
(Invitrogen) according to manufacturer’s instructions. 4 mg of total
RNA was used to generate RNA-seq libraries using TruSeq RNA
kit (Illumina) according to manufacturer’s instructions. Libraries
were multiplexed in pairs and run on a single lane of the HiSeq
2000 platform (Illumina) to generate 100 bp paired-end reads.
Amplification and analysis of CpG dinucleotide
methylation using Sanger sequencing
500 ng of genomic DNA was bisulfite converted using the
MethylCode Bisulfite Conversion Kit (Invitrogen) according to
manufacturer’s instructions. Diluted by 1:8, bisulfite-converted
DNA was amplified using PFU Turbo Cx polymerase with
primers designed with the Meth primer program (http://www.
urogene.org/methprimer/index1.html). PCR products were puri-
fied using the MultiScreen PCRm96 plate (Millipore). Sanger-
sequenced CpG dinucleotides were scored in the Sequencher 5.0
analysis software (Gene Codes Corporation). A secondary peak
was called if it was $5% of the primary peak height. The peak
height ratio was used to calculate percentage methylation at CpG
sites. Primer sequences are available on request. To ensure that we
mapped CpG dinucleotide methylation rather than methylation of
CpG disrupting SNPs (e.g. CG.TG), we carried out genomic
DNA sequencing in BN and SHR for all 14 regions containing the
differentially methylated CpG dinucleotides and only mapped
CpG dinucleotide methylation where the CpG dinucleotide was
present in both strains.
Figure 8. Distribution of methylation differences by source of variation. The boxplots show the the distribution of methylation differences
for significantly differentially methylated CpGs (white) and non-significantly differentially methylated CpGs (grey) between the parental strains, the F1
reciprocal crosses, allele specific methylation and parent-of-origin dependent methylation.
doi:10.1371/journal.pgen.1004813.g008
Table 3. Summary of differential methylation by source of variation.
Number of CpGs analysed*
Number of CpGs differentially
methylated*
Percentage of CpGs differentially
methylated
Parental strains 10,614,445 77,088 0.73%
F1 reciprocal crosses 24,887,377 2,627 0.01%
Allele specific 2,170,074 38,152 1.76%
Parent-of-origin specific 2,170,074 723 0.03%
*Strand specific methylation.
doi:10.1371/journal.pgen.1004813.t003
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Amplification and analysis of CpG dinucleotide
methylation using Fluidigm and Illumina sequencing
500 ng of genomic DNA was bisulfite converted using the
MethylCode Bisulfite Conversion Kit (Invitrogen) according to
manufacturer’s instructions. 50 ng of bisulfite-converted DNA and
target regions were PCR amplified utilising the Fluidigm 48.48
Access Array. Primers were designed with the Sequenom primer
program (http://www.epidesigner.com) and FastStart High Fidel-
ity PCR system (Roche) was used for amplification. PCR
amplification was performed for 40 cycles with an annealing
temperature of 57uC. Primer sequences are available on request.
PCR products from each sample were indexed, pooled and
purified using the Agencourt AMPure XP system (Beckman
Coulter). Sequencing libraries were prepared from the pooled
samples and sequenced on the Illumina MiSeq platform.
Demultiplexed sequencing reads were mapped and methylation
profiles generated as described in [38]. Differentially methylated
CpG dinucleotides were analysed for the presence of a disrupting
SNP or INDEL and only CpG dinucleotide methylation where the
CpG dinucleotide was present in both strains was mapped.
Rat genome reference sequence
The rat genome assembly RGSC3.4 (rn4) was used as the
reference sequence. Reference sequence files in FASTA format
were obtained from the UCSC genome browser website (ftp://
hgdownload.cse.ucsc.edu/goldenPath/rn4/chromosomes).
Genome annotation
Transcription start site, exon and intron annotations for the rat
genome assembly RGSC3.4 were obtained from the Ensembl
database (http://www.ensembl.org) version 62. CpG island
coordinates (cpgIslandGgfAndyMasked) were obtained from the
UCSC genome browser (http://genome.ucsc.edu).
BN-SHR sequence variation
We used the BN-Lx/Cub and SHR/OlaIpcv genome sequence
variation data previously reported [17], using the SNV and indel
caller described in [17].
WGBS read mapping and processing
WGBS read mapping and processing was carried out as
described in detail in [38]. In brief, WGBS reads were aligned
against the rat genome reference sequence with BWA [40] version
0.5.8a. Prior to alignment, reads were pre-processed as follows: i)
the conversion state of read pairs was masked by converting all C
base calls of read1 to Ts and all G base calls of read2 to As ii) the
first read base was clipped to avoid false negative methylation calls
from unmethylated cytosines introduced at the fragment 59 end
during the end-repair step of library preparation iii) reads were
quality trimmed at the 39 end with the -q option of BWA using a
Q score cutoff of 20.
To map reads originating from the bisulfite converted forward
strand of the genomic DNA, reads were aligned to an in silico
bisulfite-converted version of the reference sequence with all Cs
converted to Ts; to map reads originating from the bisulfite
converted reverse strand reads were aligned to the G-to-A
converted reference sequence. To reduce allele-specific mapping
bias, reads generated in SHR samples were mapped to a reference
sequence that was converted to the SHR allele at BN-SHR SNP
positions prior to C-to-T/G-to-A conversion. Reads generated in
F1 animals and thus of unknown haplotype at BN-SHR SNP
positions were mapped against a reference sequence with all SNP
positions masked by replacing them with N. Spiked-in unmethy-
lated lambda phage control DNA was mapped to the lambda
reference sequence (Genbank accession NC_001416.1) which was
in silico bisulfite converted in the same way as the rat reference
genome sequence.
After alignment, the 39 ends of overlapping read pairs were
clipped retaining the higher quality end in order to avoid duplicate
methylation calls in the overlap region. Subsequently read
mappings were filtered removing i) clonal reads ii) reads with a
mapping quality ,20 iii) read pairs mapping to both the in silico
converted forward and the in silico converted reverse strand iv)
reads with invalid mapping orientation.
Depth of coverage analysis
Depth of coverage statistics for the filtered WGBS mappings
were calculated with the DepthOfCoverage command of the
Genome Analysis Toolkit [41] version 1.1.23.
Methylation calling, differential methylation analysis and
methylation profile filtering
Mapped, processed and filtered reads were piled up with the
samtools [42] version 0.1.16 mpileup command and the number
of cytosine and thymine base calls counted at each cytosine
position. The relative methylation level at each cytosine position
was calculated as the percentage of cytosine base calls of the total
number of cytosine and thymine base calls. Methylation calls
were corrected for incomplete bisulfite conversion by subtracting
the average number of expected unconverted cytosines at the
depth of coverage at the respective position given the bisulfite
conversion rate for the respective sample prior to calculating
relative methylation levels. For WGBS libraries generated from
F1 samples the bisulfite conversion rate was calculated from the
frequency of unconverted cytosines in the unmethylated lambda
control spike-ins. For WGBS libraries generated from BN and
SHR samples, the bisulfite conversion rate was estimated by
regression analysis of non-CpG conversion rate and lambda
conversion rate in the F1 samples. Bisulfite conversion rates for
BN and SHR samples were then predicted from the non-CpG
conversion rate in these samples. Bisulfite conversion rates were
.97% for all samples.
Differential methylation at cytosines was tested for by Fisher’s
exact test on a 262 contingency table testing for independence of
strain/cross/allele and the frequency of unconverted and
converted cytosines across all replicates. P-values were adjusted
for multiple testing using the false discovery rate (FDR) method by
Benjamini and Hochberg [43].
Methylation profiles were filtered prior to multiple testing
correction i) Retaining only cytosines with a minimum
combined read coverage of 56 across a minimum of three
replicates. ii) Removing CpN dinucleotides affected by BN-SHR
sequence variation (SNP and indels) to exclude methylation
differences resulting from the disruption or deletion of methyl-
ation sites.
Hierarchical clustering and principal component analysis
of CpG methylation profiles
Methylation profiles of CpG dinucleotides with at least 56
coverage in each of the replicates/phased data sets were clustered
based on the pairwise euclidean distance between the vectors of
methylation levels for each animal scaled down to 56 coverage.
CpG dinucleotides affected by BN-SHR sequence variation (SNPs
and indels) were removed from the data set prior to the analysis.
Profiles were subsequently clustered using Ward’s minimum
variance method [44]. Distance calculations and clustering were
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carried out with the statistical software package R [45] using the
dist and hclust functions, respectively. Principal component
analysis was carried out with the pca function of the pcaMethods
R package.
Meth-QTL and physiological QTL mapping in the RI
strains
From Sanger and Illumina sequencing of PCR products, we
derived mean methylation values from the two biological replicates
for each RI strain. We carried out genome-wide linkage analysis in
the 29 BXH/HXB RI strains for all 212 CpG dinucleotides and
the average methylation percentage of all CpG within each of the
40 PCR amplicons. Linkage analysis was carried out as previously
described [14] using QTL Reaper (K.F. Manly; University of
Tennessee Health Science Center, Memphis, Tennessee) except
that a denser SNP map of 1384 markers was used [46]. To
account for non-normally distributed data, the empirical signifi-
cance of the meth-QTLs was assessed by 1 million permutations
[47]. The same genome wide correction was applied for testing
both cis and trans linkage. We defined regions as regulated in cis
or in trans by defining cis when the peak of linkage marker lay
within 5 Mbp of the genomic location of the amplicon, with other
linkages being defined as trans. Candidate genes and Gene
Ontologies for the Odfp2 and Asap2 meth-QTL interval were
taken from Ensembl release 66.
Principal component analysis of methylation
measurements in cardiomyocytes and
non-cardiomyocytes
Principal component analysis of methylation measurements in
cardiomyocytes and non-cardiomyocyte cell populations isolated
from BN and SHR cardiac tissue was carried out using the pca
function of the pcaMethods R package with unit variance scaling.
Quantitative trait methylation (QTM) analysis
Measurements of 241 phenotypic traits measured across the RI
strain panel (Table S11) were provided by Michal Pravenec.
Outliers were removed from the raw measurements within each
strain using boxplot analysis, grubb test and Nalimov test. After
outlier removal mean and standard error where calculated for
each trait and strain. Association of average locus methylation in
the RI strains and physiological phenotypes was then assessed by
Pearson’s correlation test. P-values were adjusted for multiple
testing using the false discovery rate (FDR) method by Benjamini
and Hochberg [43].
RNA-seq read mapping and differential expression
analysis
RNA-seq reads were aligned to the rat genome reference
sequence assembly RGSC3.4 (rn4) with TopHat [40] version
1.3.0. To reduce allele-specific mapping bias, reads generated in
SHR samples were mapped to a reference sequence that was
converted to the SHR allele at BN-SHR SNP positions.
Exon expression was quantified by counting read-pairs mapped
to exon locations annotated in Ensembl version 62 using the
NxtGenUtils (http://code.google.com/p/nxtgen-utils) version
0.12 CountReads command. Differential expression analysis was
carried out with DESeq [48] version 1.6.1 on the raw exon
fragment counts. The analysis was run with the default parameters
except for the estimateDispersions function which was run with the
‘pooled’ option set to true. An FDR-adjusted P-value,0.05 was
chosen as the significance threshold for differential expression.
Analysis of SNP allele frequencies at differentially
methylated CpG dinucleotides
SNP allele bias for alleles at differentially methylated CpGs was
examined by calculating the information content [49] for the
observed SNP allele frequencies at the five base pairs up- and
downstream of CpGs showing increased or decreased methylation
in the SHR and BN strains. Calculations and visualisation were
carried out with the Bioconductor seqLogo package implemented
in R. The seqLogo code was modified to take into account
nucleotide usage in the rat genome (29% A, 29% T, 21% C, 21%
G). To compare nucleotide usage around hyper- and hypomethy-
lated CpGs in rat and mouse nucleotide usage information was
obtained as personal communication from the authors of [Xie et
al., 2012]. Position frequency matrices derived from rat and mouse
nucleotide usage data were compared with the TOMTOM tool of
the MEME suite version 4.9 [25].
Phasing of WGBS reads by parental genotype
WGBS read pairs generated in the reciprocal F1 crosses that
mapped to BN-SHR SNP positions were phased by parental
genotype by determining the SNP allele in the read sequences
using the NxtGenUtils (http://code.google.com/p/nxtgen-utils)
version 0.12 PhaseRead command. C/T SNP positions were not
used for phasing because of the difficulty of distinguishing allelic
variation from bisulfite conversion at these positions in WGBS
reads. Read pairs with ambiguous allele patterns (equal frequency
of BN and SHR SNP alleles) were discarded.
Detection of allele and parent-of-origin specific
methylation differences
Allele and parent-of-origin specific differences in methylation
were detected by carrying out differential methylation analysis on
the phased F1 WGBS read data as described above for the
parental and unphased F1 data.
Allele-specific methylation differences were determined sepa-
rately for maternally and paternally derived chromosomes, i.e.
methylation on the (maternally-derived) BN allele in the
(BNxSHR)F1 cross was compared to methylation on the
(maternally derived) SHR allele in the (SHRxBN)F1 cross.
Methylation on the (paternally-derived) BN allele in the
(SHRxBN)F1 cross was compared to methylation on the
(paternally-derived) SHR allele in the (BNxSHR)F1 cross. A
CpG was reported as allele-specifically methylated if it showed a
statistically significant difference (as above) in methylation in either
or both the comparisons.
By analogy, parent-of-origin specific methylation differences
were determined by comparing methylation on the maternal and
paternal allele separately for the BN and SHR derived chromo-
somes. Only differentially methylated regions that show a
consistent direction of methylation differences in all comparisons
were reported.
Clustering of differentially methylated cytosines into
differentially methylated regions
Differentially methylated cytosines were clustered into differen-
tially methylated regions by grouping differentially methylated
cytosines not further away than 500 bp from each other
irrespective of the direction of the methylation difference using
BEDTools [50].
Gene Ontology analysis
Genes whose gene body (exons and introns) or the region
5000 bp upstream or downstream overlapped with differentially
Genetic Control of CpG Methylation
PLOS Genetics | www.plosgenetics.org 16 December 2014 | Volume 10 | Issue 12 | e1004813
methylated regions containing five or more differentially methyl-
ated CpGs showing the same direction of methylation differences
were tested for enrichment of Gene Ontology terms. As
background the set of all genes whose gene body +/25000 bp
overlapped with CpGs tested for differential methylation was used.
The Gene Ontology analysis was carried out with DAVID 6.7
[51,52] using default settings. Enriched Gene Ontology terms were
subsequently clustered by similarity with REVIGO [53] setting the
output option for ‘list size’ to ‘small’. Otherwise default settings
were used.
Supporting Information
Figure S1 Depth of coverage of quality-filtered whole genome
bisulfite sequencing data generated in the parental strains. (A)
Cumulative coverage across the genome. The plot shows the
percentage of bases (ungapped sequence of the RGSC3.4
reference assembly) covered by at least x reads. (B) Cumulative
coverage of cytosines in CpG context (CpGs on forward and
reverse strand were counted separately) (C) Cumulative coverage
of cytosines in CpG context with coverage in at least 3 replicates in
both strains (CpGs on forward and reverse strand were counted
separately). The dotted line marks the minimum coverage cut off
for CpGs included in the differential methylation analysis.
(PDF)
Figure S2 Analysis of global DNA methylation levels by
Luminometric Methylation Assay (LUMA). Genomic DNA
extracted from liver, kidney and left ventricle (LV) of BN and
SHR animals was subjected to double-digestion with EcoRI and
methylation-sensitive HpaII and methylation insensitive MspI
restriction endonucleases and global methylation quantified by
pyrosequencing. Unmeth =unmethylated control DNA, meth=
fully methylated control DNA, n= replicates. The error bars
indicate the standard deviation.
(PDF)
Figure S3 Clusters of differentially methylated CpG dinucleo-
tides. (A) Frequency plot showing the size distribution of clusters of
differentially methylated CpG dinucleotides (black bars, left-hand
y-axis) obtained when grouping adjacent differentially methylated
CpG dinucleotides not further than 500 bp away from each other.
Singletons (29,313 differentially methylated CpG dinucleotides)
are excluded from the plot. The red line shows the cumulative
frequency of differentially methylated CpG dinucleotides con-
tained within the clusters (right hand y-axis). (B) Frequency plot
showing the number of differentially methylated CpG dinucleo-
tides contained in the clusters of differentially methylated CpGs.
(PDF)
Figure S4 Distribution of methylation levels at CpG cytosines
analysed for differential methylation between BN and SHR
strains. The x-axis shows the average percent methylation across
replicates and the y-axis the number of CpG di-nucleotides.
(PDF)
Figure S5 Distribution of methylation differences across geno-
mic regions. (A) Proportion of differentially methylated CpGs
within different genomic regions compared to the rest of the
genome for CpGs inside CpG islands (TSS= transcription start
site as annotated in Ensembl version 62; TSS 500= region 500 bp
upstream and downstream of TSS; TSS 1000= region 1000 bp
upstream and downstream of TSS). (B) Proportion of differentially
methylated CpGs within different genomic regions compared to
the rest of the genome for CpGs outside CpG islands.
(PDF)
Figure S6 Scatter plots of methylation percentages obtained by
Sanger sequencing or Fluidigm and whole genome bisulfite
sequencing (WGBS) in the SHR and BN inbred strains. (A)
Methylation data were obtained by Sanger sequencing (y-axis) and
WGBS (x-axis) for 70 individual CpG dinucleotides in each of the
Brown Norway (n= 4) and the spontaneously hypertensive rat
(n = 4) strains. (B) Methylation data were obtained by Fluidigm (y-
axis) and WGBS (x-axis) for 131 individual CpG dinucleotides in
each of the Brown Norway (n = 4) and the spontaneously
hypertensive rat (n = 4) strains. Pearson’s correlation coefficent
and associated p value are given.
(PDF)
Figure S7 LOD plots of 20 meth-QTLs. The average
methylation percentage across amplicons Akr1b10, Tbc1d30,
Bl1_RAT and Rtdr1 did not show significant linkage. For
Tbc1d30 the individual CpG dinucleotides mapped in cis. LOD
scores for linkage of average amplicon methylation levels are
shown in red, LOD scores for linkage of individual CpG
dinucleotides are shown in grey. The peak of linkage is indicated
by a dashed, blue vertical line.
(PDF)
Figure S8 Methylation of individual CpG dinucleotides across
the Epha2 amplicon measured by Sanger sequencing of PCR-
amplified bisulfite-treated DNA. Seven CpG dinucleotides were
assayed by Sanger sequencing with three (*) showing significant
differential methylation (p,0.05) between the Brown Norway
(BN) and the Spontaneously Hypertensive Rat (SHR). CpG
dinucleotide 160,184,634 shows an opposing allelic effect as
methylation is decreased in the BN strain whereas at CpG
dinucleotides 160,184,557 and 160,184,560 methylation is in-
creased in the BN strain compared to SHR.
(PDF)
Figure S9 Methylation differences between BN and SHR across
different cell- and tissue-samples. Shown are average methylation
levels across each amplicon in cardiomyocyte preparations (m),
non-cardiomyoctye preparations (nm), whole heart samples (wh)
and left ventricle samples (lv). Amplicon length and number of
measured CpGs are given in brackets behind the amplicon name.
The significance of a two-way ANOVA testing for independence
of CpG methylation levels and the two factors strain and tissue are
shown below the amplicon name.
(PDF)
Figure S10 Distance to the nearest SNP and extent of
differential methylation. Histograms showing the distribution of
methylation differences between BN and SHR for CpGs at
different distances from the nearest SNP.
(PDF)
Figure S11 Distribution of methylation differences between the
parental strains depending on the alleles of SNPs directly adjacent
to the CpG dinucleotide. (A) Boxplot of the distribution of
methylation differences for BN/SHR allele changes at the
nucleotide directly upstream of the CpG dinucleotide that, based
on the motif analysis, are predicted (i) to result in decreased
methylation in SHR (red), (ii) to result in increased methylation in
SHR (blue) or (iii) to have a neutral effect on methylation (green).
The height of the box indicates the frequency of each allele
change. The total observation frequency for each group of changes
(increased, decreased, neutral) is shown by the bar plot on the
right. (B) Boxplot of the distribution of methylation differences for
BN/SHR allele changes at the nucleotide directly downstream of
the CpG dinucleotide.
(PDF)
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Figure S12 Depth of coverage of quality-filtered whole genome
bisulfite sequencing data generated in the reciprocal F1 crosses. (A)
Cumulative coverage across the genome. The plot shows the
percentage of bases (ungapped sequence of the RGSC3.4
reference assembly) covered by at least x reads. (B) Cumulative
coverage of cytosines in CpG context (CpGs on forward and
reverse strand were counted separately) (C) Cumulative coverage
of cytosines in CpG context with coverage in at least 3 replicates in
both crosses (CpGs on forward and reverse strand were counted
separately). The dotted line marks the minimum coverage cut-off
for CpGs included in the differential methylation analysis.
(PDF)
Figure S13 Differential CpG methylation between the recipro-
cal F1 crosses and allele-specific CpG methylation. (A) Distribu-
tion of relative methylation levels at cytosines analysed for
differential methylation between the reciprocal F1 crosses. (B)
Distribution of relative methylation levels at cytosines analysed for
allele-specific methylation in the F1 crosses. The histograms show
the distribution of methylation levels measured for the BN and the
SHR allele.
(PDF)
Table S1 Mapping and filtering statistics for whole genome
bisulfite sequencing reads generated in BN and SHR rats.
(PDF)
Table S2 Gene Ontology analysis of genes associated with
differentially methylated regions.
(PDF)
Table S3 CpG dinucleotides tested for linkage in recombinant
inbred strains.
(PDF)
Table S4 Trans meth-QTL interval genes.
(PDF)
Table S5 Read mapping statistics for RNA-seq reads generated
in BN and SHR rats.
(PDF)
Table S6 Summary of the results of a two-way ANOVA to test
for independence of methylation levels and the two factors strain
and cell/tissue type.
(PDF)
Table S7 Comparison of position frequency matrices of
nucleotides associated with hyper- and hypomethylated CpGs in
rat and mouse.
(PDF)
Table S8 Mapping and filtering of whole genome bisulfite
sequencing reads generated in reciprocal F1 crosses.
(PDF)
Table S9 Summary of genomic regions showing parent-of-origin
specific differences in methylation.
(PDF)
Table S10 Summary of validation of parent-of-origin specific
differences in methylation by targeted bisulfite-seq.
(PDF)
Table S11 Phenotypes tested for correlation with methylation
measurements across the RI strain panel.
(PDF)
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